Moreover, circulating tumor DNA (ctDNA), circulating tumor cells (CTCs) and serum thymidine kinase-1 activity are under investigation as liquid biopsy-based biomarkers, offering minimally invasive options for real-time monitoring. Here, TK1 is linked to neoplasm.